OraSure Technologies | OSUR - Operating Profit


OraSure Technologies reported $-13.59M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Agilent USD 444M 45M Jun/2026
AngioDynamics USD -2.51M 5.41M Sep/2025
Becton, Dickinson and Co. USD 752M 125M Jun/2026
Bio Techne USD 75.49M 21.03M Mar/2026
Bio-Rad Laboratories USD 72.6M 38.5M Jun/2026
Bruker USD 69.6M 59.4M Jun/2026
Cerus USD -1.45M 488K Dec/2024
Charles River Laboratories USD 119.89M 9K Jun/2026
Danaher USD 1.13B 217M Jun/2026
Dentsply International USD 84M 52M Jun/2026
Dexcom USD 318.3M 63M Jun/2026
Illumina USD 260M 21M Jun/2026
Integra LifeSciences USD 41.29M 29.82M Jun/2026
Intuitive Surgical USD 977.6M 117.9M Jun/2026
IQVIA Holdings USD 2.6B 2.03B Jun/2026
Mesa Laboratories USD 5.78M 2.27M Dec/2024
Mettler Toledo International USD 287.55M 53.61M Jun/2026
Myriad Genetics USD -3M 20.3M Dec/2025
OraSure Technologies USD -13.59M 2.13M Dec/2025
Quidel USD -15.3M 16.5M Jun/2026
Repligen USD 21.13M 1.15M Jun/2026
Revvity USD 126.14M 43.36M Jun/2026
STAAR Surgical USD 10.1M 7.3M Jun/2026
Thermo Fisher Scientific USD 2.18B 273M Jun/2026
Trinity Biotech USD -1.3M 796K Dec/2025
Waters USD -86M 234M Jun/2026